Trial intelligence / Profile preview

TCA + Glycolic Acid Peel for Hand Lentigines

NCT05471947Phase 4Completed

Sponsor
Main Line Center for Laser Surgery
Start
Mar 2023
Primary completion
Dec 2023
Modality
Transdermal Patches, Hydrogel Systems, Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of trichloroacetic acid and Glycolic acid in lentigo, sponsored by Main Line Center for Laser Surgery. Primary endpoint: Improvement in hand lentigines on a 5-point scale. Started Mar 2023; status: completed.

02

Drugs

trichloroacetic acidGlycolic acid
03

Conditions

lentigo

Beyond the preview

Go deeper on NCT05471947.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05471947.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call